Bayer Kogenate FS
Bayer HealthCare, Biological Products Division

Contact Search Press Sitemap  
HomePatients & CaregiversHealthcare ProfessionalsPrescribing Information
Prescribing Information
Important Safety Information
Administration
HCP Video
Product Benefits
Hemophilia Awards
EZ-Log
Bayer Factor Solutions
Rep Finder
Summer Camps
Patient Education Materials
HCP Resources
HCP FAQ
Bayer Links
Bayer Global
Living with Hemophilia
   General Conditions of Use
Privacy Statement
Imprint
  
 
  

Patient Assistance

Kogenate® FS Patient Assistance Program (PAP)
Bayer has developed the Kogenate® FS Patient Assistance Program (PAP) for patients who 1) need short-term assistance with obtaining Kogenate FS treatment but have no insurance coverage, or 2) need assistance because their coverage does not include Kogenate FS. Through this assistance program, patients may be eligible to receive up to a three-month supply of Kogenate FS.

Eligibility

  • Patients with no insurance who require assistance for Kogenate FS treatment, or patients who need assistance because their current insurance policy will not cover Kogenate FS, will be considered for the program.
  • Patients must meet the program's financial criteria.
  • Patients must be US citizens or legal residents of the United States.
  • Medicaid spend-down patients are not eligible.

Prescreening process
Patients should call the Bayer Reimbursement HELPlineā„¢ at 800.288.8374 to see if they qualify for the Kogenate® FS PAP. A Program Analyst will assess each patient's specific case by walking him through a step-by-step prescreening process. During this process, the Program Analyst will examine all possibilities for that patient's treatment coverage, such as state prescription plans, Medicaid, or community programs, and provide any information that is uncovered.

Have your patients call 800.288.8374 to see if they are eligible for the Kogenate® FS Patient Assistance Program.



Reimbursement Help
PSI
Patient Coupon Program




Bayer Hemophila Awards
Bayer provides grants
to early career investigators, fellows in training, and other allied healthcare professionals.
Learn More


 
  

Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.

Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.